Table 1.
The demographics and clinical characteristics for NAFLD and Non-NAFLD subjects
| Characteristic | NAFLD (n=292) | Non-NAFLD (n=387) | P Value |
|---|---|---|---|
| Age, year | 48.89±11.57 | 41.97±12.17 | 0.000 |
| Gender, Male/Female | 177/114 | 134/251 | 0.000 |
| BMI, kg/m2 | 26.25±2.55 | 22.13±2.56 | 0.000 |
| SBP, mmHg | 123.95±19.82 | 119.32±0.96 | 0.282 |
| DBP, mmHg | 77.85±0.86 | 75.80±0.65 | 0.089 |
| WC, cm | 79.32±0.42 | 77.56±0.32 | 0.003 |
| HP, cm | 91.60±0.36 | 92.05±0.27 | 0.366 |
| TP, g/L | 73.83±0.29 | 73.56±0.22 | 0.497 |
| Albumin, g/L | 46.26±0.24 | 45.80±0.18 | 0.159 |
| Globulin, g/L | 28.10±0.36 | 27.79±0.27 | 0.538 |
| A/G | 1.70±0.02 | 1.69±0.02 | 0.575 |
| TBIL, μmol/L | 12.59±0.60 | 13.14±0.45 | 0.502 |
| DBIL, μmol/L | 5.39±0.22 | 5.23±0.17 | 0.606 |
| TBA, μmol/L | 3.69±0.28 | 3.05±0.25 | 0.137 |
| ALT, U/L | 30.77±1.70 | 20.60±1.29 | 0.000 |
| AST, U/L | 26.42±1.46 | 24.30±1.31 | 0.339 |
| FBG, mmol/L | 5.47±0.11 | 5.17±0.09 | 0.055 |
| LDL-C, mmol/L | 3.041±0.06 | 2.88±0.05 | 0.068 |
| TG, mmol/L | 2.25±0.10 | 1.51±0.08 | 0.000 |
| TC, mmol/L | 5.18±0.07 | 4.95±0.06 | 0.025 |
| HDL-C, mmol/L | 1.40±0.03 | 1.52±0.02 | 0.001 |
Note: Values are expressed as mean±SD and compared by analysis of covariance corrected for Age, Gender and BMI, except for Age and BMI by t test(values are expressed as mean±SD) and gender by Chi-square test(values are expressed as n). A P-value < 0.05 was considered as statistically significant (in bold).
Abbreviations: BMI, Body Mass Index; SBP, systemic blood pressure; DBP, diastolic blood pressure; WC, Waist circumference; HP, Hip circumference; TP, Total Protein; A/G, the ratio of albumin to globulin; TBIL, total bilirubin; DBIL, direct bilirubin; TBA, total bile acid; ALT, glutamic-pyruvic transaminase; AST, glutamic oxalacetic transaminase; FBG, fasting blood-glucose; LDL-C, low density lipoprotein cholesterin; TG, triglyceride; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; NAFLD, nonalcoholic fatty liver disease.